from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2103c/vapC37

LFCtreatmentdescriptionclass of inhibitor

0.370

Amikacinug/mL Amikacintranslation

-0.101

Cap5-10ug/mL Capreomycintranslation

0.505

Rox10-50 ug/mL Roxithromycintranslation

0.674

SM2-5 ug/mL Streptomycintranslation

1.336

Tet5-10 ug/mL Tetracyclinetranslation

-0.367

Rif0.2-5ug/mL Rifampicintranscription

0.229

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.691

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.333

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.058

CPZ10-50 ug/mL Chlorpromazinerespiration

0.366

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.201

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.811

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.338

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.042

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.384

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.891

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.249

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.015

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.006

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.144

Nigericin50 uM Nigericinrespiration

0.185

TRC10-150 ug/mL Triclosanrespiration

-0.637

TRZ10-25 ug/mL Thioridazinerespiration

4.746

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

1.189

menadione6-10 ug/mL Menadionerespiration

-0.221

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.268

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.654

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.869

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.263

NRP_1Non-replicating persistence stage 1dosRassociated

0.147

Amp0.2mg/mL AmpicillincellWall

0.050

Cephalexin20-100 ug/mL CephalexincellWall

-0.156

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.318

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.242

EMB10-20 ug/mL EthambutolcellWall

-0.020

Eta12-40 ug/mL EthionamidecellWall

0.187

INH0.2-0.4 ug/mL IsoniazidcellWall

0.020

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.719

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.644

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.233

BZA0.12 mg/mL BenzamidearomaticAmides

-0.301

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.090

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.560

H2O24 mM hydrogen peroxideDNAdamaging

-0.272

Levo10 ug/mL LevofloxacinDNAdamaging

-0.430

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.310

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.394

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.291

UVUV-irradiationDNAdamaging

-0.356

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.856

Antimycin12.5-50 ug/mL Antimycin A?

-0.575

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.552

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.554

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.367

PA8240.2-2 ug/mL PA-824?

1.310

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.179

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.271

Verapamil50 uM Verapamil?

0.327

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.315

methoxatin10-20 ug/mL Methoxatin?